Quarterly ResultMay 6, 2026, 04:18 PM
Accuray Q3 Net Loss $(11.8)M; Nasdaq Bid Price Non-Compliance
AI Summary
Accuray reported a significant increase in net loss for the three and nine months ended March 31, 2026, alongside a decrease in total net revenue. The company also received a notice from Nasdaq regarding non-compliance with the minimum bid price rule, giving it until August 3, 2026, to regain compliance. Macroeconomic factors, supply chain issues, and reduced capital deployment for radiotherapy equipment continue to impact financial performance.
Key Highlights
- Nasdaq notified Accuray of non-compliance with the $1 minimum bid price rule on February 2, 2026.
- Net loss for Q3 2026 significantly increased to $(11.8) million from $(1.3) million in Q3 2025.
- Total net revenue for Q3 2026 decreased by 7.4% to $104.8 million from $113.2 million in Q3 2025.
- Net loss per share for Q3 2026 was $(0.09), compared to $(0.01) in Q3 2025.
- For the nine months, net loss widened to $(47.3) million from $(2.7) million year-over-year.
- Operating activities used $(9.4) million cash for the nine months, a shift from $12.6 million provided in prior year.
- Cash and cash equivalents decreased to $38.1 million as of March 31, 2026, from $57.4 million on June 30, 2025.
- Total stockholders' equity decreased to $41.7 million from $81.2 million over the nine months.